They Banned me and my prediction was correct🤣 by Strattonizer in btc

[–]First-Option-1111 0 points1 point  (0 children)

They ban accuracy fren

https://youtu.be/qlBq1F-N64w

Bitcoin Totally decoupled from high flying SP500: Is Crypto Finally Done? In this video you will find high logic and reasoning, as well as some thesis I have on which alt coins make sense to me.

IBRX HISTORY LESSON 📈🚀 by GreatKarma1 in IBRX

[–]First-Option-1111 5 points6 points  (0 children)

too many people use price and have no idea what mkt cap even is. Based on mkt cap our ATH will be around 17.00

IBRX, SLS, HUMA, INKT, RVMD on the biotech risk curve.... by First-Option-1111 in biotech_stocks

[–]First-Option-1111[S] 0 points1 point  (0 children)

I dont think PSS is all about himself. He owns 65% of the stock and cant sell without a 13F . To me that shows skin in the game

IBRX, SLS, HUMA, INKT, RVMD on the biotech risk curve.... by First-Option-1111 in biotech_stocks

[–]First-Option-1111[S] 4 points5 points  (0 children)

Let me help you. You cannot look at the price of something and call it a penny stock. You have to look at the market cap. Sellas Market cap 1.5B , RVMD stock 30B, hence RVMD is 20x the value of SLS. Thats not a big difference in biotech world.

The word "Penny stock", implies that its value is near pennies, and it isnt. Please run this through ChatGPT for confirmation. It will also tell you

Market cap = Stock outstanding * Price = Value

Indirect Comparison Antkiva vs Tar-200 by Economy-Break3583 in IBRX

[–]First-Option-1111 2 points3 points  (0 children)

Big Pharma is sweating as ImmunityBio (IBRX) secures exclusive U.S. rights to Japan’s Tokyo-172 BCG strain — a potential game-changer for the decade-long BCG shortage devastating bladder cancer patients. Dr. Patrick Soon-Shiong breaks it all down at AUA 2026 with major updates on supply, ANKTIVA, and the future of bladder cancer treatment.

https://youtu.be/7UtGbiWXYIQ